The global cytokine market is growing with a CAGR of 6.2% during the forecast period of 2022-2028; Cytokines are small proteins that are crucial in controlling the transition and activity of other immune system cells and blood cells. When discharged, they signal the immune system to do its job. Cytokines influence the growth of all blood cells and other cells that support the body’s immune and inflammation responses. They also help promote anticancer activity by sending signals that can help make abnormal cells die and normal cells live longer.
Cytokines are the cell signaling molecules secreted from the various body cells. Cytokines are proteins that recreate an important role as messengers between cells and control different physiological and metabolic activities. Cytokines control inflammatory responses, promote blood cell production, and stimulate tissue development & maintenance. Cytokine is a big family of small proteins, including tumor necrosis factors, interleukins, interferons, lymphokines, and chemokines.
Some cytokines formed into protein therapeutics to treat bone-related diseases, anemia, cancer, infection, and multiple sclerosis.
The growing number of cancer patients acquiring treatment is estimated to drive the global cytokines market growth. A significant increase in awareness of therapeutic opportunities for cancer and related disorders has resulted in global cytokines market growth. Transforming lifestyle habits also contribute to the prevalence of cancer and boost the cytokines market growth. For example, By the World Health Organization, 19.2 million new cases were diagnosed with cancer worldwide.
Cytokinesis is experiencing a burgeoning growth due to the rising number of diagnostic, therapeutic, and prophylactic applications of cytokines in different healthcare centers worldwide. It is mainly due to an effective chemical synthesis of cytokines that promotes the quality production of vaccines and the effect of other treatment procedures for different ailments. The addition of several cytokine-based drugs by chief players working in this market to their research portfolios is also anticipated to drive the growth of the global cytokines market.
A rise in the government initiatives to accelerate research and development of novel therapies for the treatment of cytokine will uplift the market growth, also increase the awareness about treatment and technological improvement, rise in the prevalence of the disease and expand the healthcare expenditures all over the globe are some of the critical factors among others, driving the cytokine release syndrome drug market. Moreover, the rise in the technological advancement and modernization in the healthcare devices used and the increase in the demand from occurring economies will further create new opportunities for the cytokine market in 2022-2028.
Stringent regulatory conditions for drug clearance are expected to hinder global cytokines market growth. Less diagnosis rate and treatment adoption due to inadequate economic conditions in regions like the Middle East & Africa challenges the global cytokines market growth. The unavailability of established healthcare infrastructure is also one of the major restraining elements for global cytokines market growth in less developed countries. Damaging effects caused due to the intake of drugs will challenge the growth of the global cytokines market.
Before the covid-19 period, Increasing research and development activities were anticipated to favor the growth of the cytokines market and increasing life science research funding to promote the growth of the cytokines market. The increasing prevalence of diseases such as cancer and skin disorders is expected to drive the growth of the cytokines market. The growing market for regenerative medicines propels the growth of the cytokines market. The growing demand for cytokines for wound management and cancer therapeutics is anticipated to drive growth.
During the covid-19 period, the demand in the cytokines market has increased the pandemic in various ways, either because of the lockdowns and stringent guidelines or because of the covid-19 virus itself in some cases, such as: Based on therapeutic applications, may use cytokines treatments for diseases such as arthritis, cancer, asthma and airway inflammation. As a result of the pandemic, respiratory problems (specifically in covid-19 patients) and arthritis (as a result of lifestyle changes) have increased, resulting in the market’s growth.
After the covid-19 period, the increasing number of investments and partnerships to develop cytokine therapies to treat cancer and autoimmune diseases would accelerate the market expansion in the coming years. For Example-In September 2020, Synthekine Inc. increased USD 82.0 million through contests of series funding. The company is committed to developing cytokine therapeutics to treat cancer and autoimmune disorders.
Based on product type, the global cytokines market is segmented into Tumor Necrosis Factor-TNF, Interleukins (IL), Interferons, Chemokines and others. Tumor necrosis factor TNF maintains the highest CAGR in the global cytokines market. Tumor necrosis factor (TNF) is a 185-aminoacid glycoprotein initially described to induce necrosis in certain tumors. It stimulates the critical phase of the immune response. This potent pyrogenic cytokine is one of the first to be discharged in response to a pathogen and can exert its impact on many organs.
Based on application, the global cytokines market is segmented into Dermatology, Orthopedic, Cancer, Respiratory and others. Cancer is anticipated to hold the largest share of the market. The combination of cytokines produced in the cancer microenvironment has an essential role in cancer pathogenesis. Cytokines released in reaction to infection, inflammation, and immunity can function to hinder cancer development and progression. Alternatively, cancer cells can react to host-derived cytokines that encourage growth, attenuate apoptosis, and promote invasion and metastasis. Cytokines have been examined clinically with new engineered cytokine mutants (superkines), chimeric antibody-cytokine fusion proteins (immunokines), anticancer vaccines, checkpoint inhibitors, and cancer-directed monoclonal antibodies to improve their antibody-dependent cellular cytotoxicity or support cellular responses and anticancer efficacy.
Based on region, the global cytokines market is segmented into North America, Europe, Asia-Pacific, South America and The Middle East & Africa. North America is anticipated to monopolize the global cytokines market as growing demand for cytokines products and increasing research and development activities. Europe is predicted to contribute the second-highest revenue share in the global cytokines market to a growing number of clinical trials and drug development actions.
The Asia Pacific is expected to increase with the highest growth rate in the cytokines market as many pharmaceutical manufacturers, biotechnology companies and academic institutions in the Asia Pacific region. India, South Korea & China cytokines markets are expected to grow at a more increased growth rate due to rising government research and development funding.
The companies include Hoffmann-La Roche Ltd., Merck KGaA, Lonza Group Ltd., Thermos Fisher Scientific, Abcam PLC, General Electric Company, Meridian Bioscience Inc., GenScript Biotech Corp., Applied Biological Materials (ABM) Inc., Randox Laboratories Ltd. and other prominent players in the global cytokines market.
Key Stakeholders
Report Attribute | Details |
---|---|
Revenue in 2021 | USD Million |
The revenue forecast in 2028 | USD Million |
Growth rate | CAGR of 6.2 % from 2022 to 2028. |
Historical data | 2017 – 2020 |
Base Year | 2021 |
Forecast period | 2022 – 2028 |
Region covered | North America, Europe, Asia-Pacific, South America, and Middle East & Africa |
Key companies Profiled | Hoffmann-La Roche Ltd., Merck KGaA, Lonza Group Ltd., Thermos Fisher Scientific, Abcam PLC, General Electric Company, Meridian Bioscience Inc., GenScript Biotech Corp., Applied Biological Materials (ABM) Inc. and Randox Laboratories Ltd are the key players. |
By Product Type
By Application
By End-User
By Region
Middle East Cyber Security Market
Variable Frequency Drive Market
Global Gaming Peripherals Market
Real Estate Crowdfunding Market
The global cytokine market is growing with a CAGR of 6.2% during the forecast period of 2022-2028.
The growing number of cancer patients acquiring treatment is estimated to drive the global cytokines market growth. A significant increase in awareness of therapeutic opportunities for cancer and related disorders has resulted in global cytokines market growth. Transforming lifestyle habits also contribute to the prevalence of cancer and boost the cytokines market growth.
Stringent regulatory conditions for drug clearance are expected to hinder global cytokines market growth. Less diagnosis rate and treatment adoption due to inadequate economic conditions in regions like the Middle East & Africa challenges the global cytokines market growth. The unavailability of established healthcare infrastructure is also one of the major restraining elements for global cytokines market growth in less developed countries. Damaging effects caused due to the intake of drugs will challenge the growth of the global cytokines market.
Hoffmann-La Roche Ltd., Merck KGaA, Lonza Group Ltd., Thermos Fisher Scientific, Abcam PLC, General Electric Company, Meridian Bioscience Inc., GenScript Biotech Corp., Applied Biological Materials (ABM) Inc. and Randox Laboratories Ltd are the key players in the global cytokines market.
The rise in the technological advancement and modernization in the healthcare devices used and the increase in the demand from occurring economies will further create new opportunities for the cytokine market.
Analyst support
After evaluating your requirements and addressing your technical problems, the expert analyst will resolve your query directly.
Customer satisfaction
According to your needs, our expert team will assist you with the capabilities, services, and proper research needs to be required and customize the report accordingly.
Inimitable expertise
Our expert team will create unrivaled reviews to provide you with a deep understanding of the reports.
Assured quality
We have created a systematic way to determine standards and satisfy your expectations.
Instant delivery
Unlike others, we provide you a great deal of instant delivery in the form of PDF/PPT/Word Doc directly to your email address within 24 hours after receiving full payment.
Privacy policy
We understand the inkling of your privacy, we will never misuse your email address.
Custom research service
We are giving you an opportunity through which you can directly ask our expert analyst to customize an exclusive study of the report to serve your research needs.
Quality & accuracy
We provide you with the accurate quality of the customized study of an exclusive report according to your research need.
Data visualization
As the business world’s growing faster every day, we understand the value of data management. We will create the reports by keeping all the visual data sets and metrics in the charts.
Information security
We truly respect your privacy and promise to keep your personal and confidential information safe and secure.